Search
for
Sort by
Research 30 of 1000+
- COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings
- COVID-19 and Sex Differences
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- COVID-19: Pulmonary and Extra Pulmonary Manifestations
- COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations
- Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- COVID-19 vaccines while pregnant or breastfeeding
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- COVID‐19 with dermatologic manifestations and implications: An unfolding conundrum
- COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine
- Telogen effluvium: a sequela of COVID‐19
- COVID‐19 and cutaneous manifestations: A review of the published literature
- The impact of SARS-CoV-2 and COVID-19 on male reproduction and men’s health
- What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy
- Telogen effluvium associated with COVID‐19 infection
- Teledermatology in the COVID-19 pandemic: A systematic review
- Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management
- COVID‐19 and dermatology: a comprehensive guide for dermatologists
- Time of onset and duration of post-COVID-19 acute telogen effluvium
- Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
- The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic
- Clinical symptoms of hyperandrogenic women diagnosed with COVID‐19
- Male balding is a major risk factor for severe COVID-19
- Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
- Alopecia and grey hair are associated with COVID‐19 Severity
- Hormonal trends in patients suffering from long COVID symptoms
- A systematic review of acute telogen effluvium, a harrowing post‐COVID‐19 manifestation